63 related articles for article (PubMed ID: 34278503)
1. Tumorigenic effect of
Yang L; Li N; Wang M; Zhang YH; Yan LD; Zhou W; Yu ZQ; Peng XC; Cai J
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278503
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of telomerase in cancer.
Akincilar SC; Unal B; Tergaonkar V
Cell Mol Life Sci; 2016 Apr; 73(8):1659-70. PubMed ID: 26846696
[TBL] [Abstract][Full Text] [Related]
3. Exploring the epigenetic regulation of telomerase reverse transcriptase (TERT) in human cancer cell lines.
McKelvey BA; Zeiger MA; Umbricht CB
Mol Oncol; 2020 Oct; 14(10):2355-2357. PubMed ID: 32920953
[TBL] [Abstract][Full Text] [Related]
4. Copy-number-gain of telomerase reverse transcriptase (hTERT) is associated with an unfavorable prognosis in esophageal adenocarcinoma.
Lyu SI; Popp FC; Simon AG; Schultheis AM; Zander T; Fretter C; Schröder W; Bruns CJ; Schmidt T; Quaas A; Knipper K
Sci Rep; 2023 Oct; 13(1):17699. PubMed ID: 37848472
[TBL] [Abstract][Full Text] [Related]
5. TERT Promoter Methylation Is Oxygen-Sensitive and Regulates Telomerase Activity.
Dogan F; Forsyth NR
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38275760
[TBL] [Abstract][Full Text] [Related]
6. Targeting telomerase for cancer therapy.
Guterres AN; Villanueva J
Oncogene; 2020 Sep; 39(36):5811-5824. PubMed ID: 32733068
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations.
Tornesello ML; Cerasuolo A; Starita N; Amiranda S; Bonelli P; Tuccillo FM; Buonaguro FM; Buonaguro L; Tornesello AL
Front Cell Dev Biol; 2023; 11():1286683. PubMed ID: 38033865
[TBL] [Abstract][Full Text] [Related]
8. TERC promotes non-small cell lung cancer progression by facilitating the nuclear localization of TERT.
Sun H; Li X; Long Q; Wang X; Zhu W; Chen E; Zhou W; Yang H; Huang C; Deng W; Chen M
iScience; 2024 Jun; 27(6):109869. PubMed ID: 38799568
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of mitochondrial telomerase reverse transcriptase mediates the preventive effect of physical exercise on pathological cardiac hypertrophy via improving mitochondrial function and inhibiting oxidative stress.
Li S; Xin Q; Fang G; Deng Y; Yang F; Qiu C; Yang Y; Lan C
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166859. PubMed ID: 37643691
[TBL] [Abstract][Full Text] [Related]
10. The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?
Di Nunno V; Aprile M; Bartolini S; Gatto L; Tosoni A; Ranieri L; De Biase D; Asioli S; Franceschi E
Cells; 2023 Dec; 13(1):. PubMed ID: 38201248
[TBL] [Abstract][Full Text] [Related]
11. Telomerase inhibitors TMPyP4 and thymoquinone decreased cell proliferation and induced cell death in the non-small cell lung cancer cell line LC-HK2, modifying the pattern of focal adhesion.
Garnique AMB; Rezende-Teixeira P; Machado-Santelli GM
Braz J Med Biol Res; 2023; 56():e12897. PubMed ID: 37909496
[TBL] [Abstract][Full Text] [Related]
12. Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer.
Batsios G; Taglang C; Tran M; Stevers N; Barger C; Gillespie AM; Ronen SM; Costello JF; Viswanath P
Clin Cancer Res; 2022 Aug; 28(16):3526-3536. PubMed ID: 35679032
[TBL] [Abstract][Full Text] [Related]
13. Two co-inherited SNPs of the telomerase reverse transcriptase (TERT) gene are associated with Iraqi patients with lung cancer.
Lawi ZK; Alkhammas AH; Elerouri M; Ben AI; Al-Shuhaib MBS
J Med Biochem; 2023 Oct; 42(4):694-705. PubMed ID: 38084250
[TBL] [Abstract][Full Text] [Related]
14. Assessment of MYC and TERT copy number variations in lung cancer using digital PCR.
Brik A; Wichert K; Weber DG; Szafranski K; Rozynek P; Meier S; Ko YD; Büttner R; Gerwert K; Behrens T; Brüning T; Johnen G
BMC Res Notes; 2023 Oct; 16(1):279. PubMed ID: 37858127
[TBL] [Abstract][Full Text] [Related]
15. Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates.
Fisher JL; Wilk EJ; Oza VH; Gary SE; Howton TC; Flanary VL; Clark AD; Hjelmeland AB; Lasseigne BN
FEBS Open Bio; 2024 May; 14(5):803-830. PubMed ID: 38531616
[TBL] [Abstract][Full Text] [Related]
16. The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.
Liu B; Liu XY; Wang GP; Chen YX
Sci Rep; 2024 Mar; 14(1):5184. PubMed ID: 38431660
[TBL] [Abstract][Full Text] [Related]
17. Association of TERT (rs2736098 and rs2736100) genetic variants with elevated risk of hepatocellular carcinoma: a retrospective case-control study.
Seif Eldin WR; Saad EA; Monier A; Elshazli RM
Sci Rep; 2023 Oct; 13(1):18382. PubMed ID: 37884663
[TBL] [Abstract][Full Text] [Related]
18. A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT).
Maggadóttir SM; Kvalheim G; Wernhoff P; Sæbøe-Larssen S; Revheim ME; Josefsen D; Wälchli S; Helland Å; Inderberg EM
Front Oncol; 2022; 12():1031232. PubMed ID: 36439452
[TBL] [Abstract][Full Text] [Related]
19. Sanguinarine, identified as a natural alkaloid LSD1 inhibitor, suppresses lung cancer cell growth and migration.
Qin TT; Li ZH; Li LX; Du K; Yang JG; Zhang ZQ; Wu XX; Ma JL
Iran J Basic Med Sci; 2022 Jun; 25(6):781-788. PubMed ID: 35949313
[TBL] [Abstract][Full Text] [Related]
20. Role of
Zhou W; Yan LD; Yu ZQ; Li N; Yang YH; Wang M; Chen YY; Mao MX; Peng XC; Cai J
Oncol Lett; 2022 Jun; 23(6):181. PubMed ID: 35527776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
